Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP-L vs Botox vs Corticoids for Lateral Epicondylalgia
NCT02325063Terminated
- Sponsor
- CHU Nîmes
- Start
- Dec 2015
- Primary completion
- May 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Randomised, double-blind trial of Leukocyte-Rich Platelet-Rich Plasma in lateral epicondylitis (3 arms), sponsored by CHU Nîmes. Primary endpoint: Visual Analog Scale for Pain at 6 months. Started Dec 2015; status: terminated.
02
Drugs
Leukocyte-Rich Platelet-Rich Plasma
03
Conditions
lateral epicondylitis
Beyond the preview
Go deeper on NCT02325063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02325063.